<i>TP53</i> Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Jennifer Marvin‐Peek(The University of Texas MD Anderson Cancer Center), Michael Byrne(Vanderbilt University Medical Center), Adetola A. Kassim(Vanderbilt University), Michael R. Savona(Vanderbilt University), Brian G. Engelhardt(Vanderbilt University Medical Center), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Tae Kon Kim(Vanderbilt University), Ashwin Kishtagari(Memorial Sloan Kettering Cancer Center), Emily F. Mason(Vanderbilt University Medical Center), Bipin N. Savani(Vanderbilt University Medical Center), Heidi Chen(Vanderbilt University Medical Center), Reena Jayani(Vanderbilt University Medical Center)
Cited by 1
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
|Cell stem cell|2017|851
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633